Home › Learn › Questions › Buying
What is cherry-picking in peptide testing?
The short answer
Cherry-picking is showing only the tests that came out well. It happens at two points: choosing which vial to send, and choosing which results to publish. Both are available to any vendor whose laboratory lets clients control publication, and neither requires a single false number to produce a misleading overall picture.
In detail
Selection at the sample stage is defeated by blind purchasing. Selection at the publication stage is defeated only by a laboratory policy that removes the choice.
For a buyer reading a vendor's results page, the useful question is not whether the shown results are real but what fraction of tests run they represent — a number that is usually unavailable.
Mandatory publication makes that question answerable, which is why it is a condition of testing with us rather than a feature.
Related questions
People also ask
Iberian Analytical opens in Q1 2027 — €99 per test, 48–72 h target, and every result published in a public database, mandatory and free. Nothing is sold on this site today. Leave an email and we will write once, when the laboratory starts issuing certificates.
Have a question that is not here? Write to [email protected] — we answer in public, and every real question becomes a page.